Try our Advanced Search for more refined results
May 14, 2013
Bayer Pharma AG et al v. Par Pharmaceutical Inc. et al
Case Number:
1:13-cv-00845
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
May 15, 2013
Bayer Hits Par With Patent Suit Over Staxyn Generic
Bayer Pharma AG on Tuesday hit generic-drug maker Par Pharmaceutical Inc. with a suit in Delaware federal court, accusing its rival of infringing on two patents with a planned generic version of erectile dysfunction treatment Staxyn.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login